Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels

von Meijer, Dennie, van Moorselaar, R. Jeroen A., Vis, André N., Bijnsdorp, Irene V.
Veröffentlicht in Cancers (Basel) (2019)

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers

von Luining, Wietske I., Meijer, Dennie, Dahele, Max R., Vis, André N., Oprea-Lager, Daniela E.
Veröffentlicht in Diagnostics (Basel) (2021)

Zoonotic Endocarditis in a Man, the Netherlands

von Sleutjens, Janneke, Meijer, Dennie, Meregalli, Paola G., Bakker, Leendert, Wagenaar, Jaap A., Duim, Birgitta, Zomer, Aldert
Veröffentlicht in Emerg Infect Dis (2019)

External Validation of Two Nomograms Developed for (68)Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer (18)F-DCFPyl: Is Prediction of the Optimal Timing of Salv...

von Luiting, Henk B., Remmers, Sebastiaan, Meijer, Dennie, Vis, André N., Donswijk, Maarten, Oprea-Lager, Daniela E., Emmett, Louise, Rauscher, Isabel, Van der Poel, Henk G., Roobol, Monique J., van Leeuwen, Pim J.
Veröffentlicht in Eur Urol Open Sci (2021)

Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

von Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.
Veröffentlicht in PLoS One (2020)

Management impact of (18)F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study

von Meijer, Dennie, van Leeuwen, Pim J., Oosterholt, Pepijn M. J., Bodar, Yves J. L., van der Poel, Henk G., Hendrikse, N. Harry, Donswijk, Maarten L., Wondergem, Maurits, Vellekoop, Annelies E., van Moorselaar, R. Jeroen A., Nieuwenhuijzen, Jakko A., Oprea-Lager, Daniela E., Vis, André N.
Veröffentlicht in Eur J Nucl Med Mol Imaging (2021)